Recent Activity

Loading...

MYNZ

Mainz Biomed N.V. · NASDAQ

Performance

-18.17%

1W

-33.94%

1M

-21.48%

3M

-76.92%

6M

-37.93%

YTD

-85.71%

1Y

Profile

Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.

Technical Analysis of MYNZ 2024-05-03

Overview:

In analyzing the technical indicators for MYNZ over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights...

See more ...

Recent News & Updates